page back

 

Flecainide [fle kay' nide]
(Class I, Na+ Channel Blocker)
  • Prescribed in patients prone to supraventricular arrhythmias, including atrial fibrillation, when no structural disease is present.

  • Most serious of adverse effects is induction of potentially lethal arrhythmias such as reentrant ventricular tachyarrhythmias.